Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Toxicology and Pharmacology of Drugs Developed for Cancer, AIDS, and
McCormick, David
Search 215 grants from David McCormick
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Distracted Pedestrian Behavior: Intervention to Increase Safety
Targeting MFG-E8 as Melanoma Immunotherapy
A comprehensive approach to breast cancer susceptibility across the risk spectrum
Combining bioavailability assays with modeling to predict PCBs in fish after reme
Natural Kill of HSV-1 Infected Targets: Basic Biology
Recently added grants:
Neutrophil plasticity in autoimmune disease
Enhance Arthroplasty Research through Electronic Health Records and Nlp-Enabled Informatics
H. pylori-induced Inflammation and Gastric Cancer
Understanding the mechanism of action for anticancer sulfonamides that target splicing
Directing the metabolic fate of CAR T cells
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM42202-13-0-0
Application #
7543410
Study Section
Project Start
2004-04-01
Project End
2011-03-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
$1,272,233
Indirect Cost
Related projects
NIH 2008
N01 CA
Preclinical Toxicology and Pharmacology of Drugs for Cancer
/ Iit Research Institute
$1,741,870
NIH 2007
N01 CA
Preclinical Toxicology and Pharmacology of Drugs Developed for Cancer, AIDS, and
McCormick, David /
$1,272,233
NIH 2007
N01 CA
Preclinical Toxicology and Pharmacology of Drugs for Cancer
/
Comments
Be the first to comment on David McCormick's grant